Disease-modifying osteoarthritis drugs (DMOADs): new trends in osteoarthritis therapy

Autor: O. A. Shavlovskaya, О. А. Gromova, A. Yu. Kochish, Yu. D. Yukhnovskaya, I. D. Romanov, I. A. Bokova

Publikováno v: Фармакоэкономика, Vol 16, Iss 3, Pp 482-499 (2023)

The review examines pharmacological agents that can have potential disease-modifying osteoarthritis drugs (DMOADs) status. DMOADs prevent the progression and further structural joint damage (structure-modifying effect), leading to a decrease in sympt

Externí odkaz: https://doaj.org/article/25c7496b78894062b3703d4595d8f68f

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Overcoming barriers for intra-articular delivery of disease-modifying osteoarthritis drugs

Autor: Gao, Jingjing, Xia, Ziting, Mary, Helna B., Joseph, John, Luo, James N., Joshi, Nitin

Publikováno v: In Trends in Pharmacological Sciences March 2022 43(3):171-187

A brief review of current treatment options for osteoarthritis including disease-modifying osteoarthritis drugs (DMOADs) and novel therapeutics.

Autor: Jiang P; The Second Affiliated Hospital Zhejiang University School of Medicine Changxing Campus, Taihu Middle Road, Changxing County, Zhejiang Province, China., Hu K; The Second Affiliated Hospital Zhejiang University School of Medicine Changxing Campus, Taihu Middle Road, Changxing County, Zhejiang Province, China., Jin L; The Second Affiliated Hospital Zhejiang University School of Medicine Changxing Campus, Taihu Middle Road, Changxing County, Zhejiang Province, China., Luo Z; The Second Affiliated Hospital Zhejiang University School of Medicine Changxing Campus, Taihu Middle Road, Changxing County, Zhejiang Province, China.

Publikováno v: Annals of medicine and surgery (2012) [Ann Med Surg (Lond)] 2024 Jun 04; Vol. 86 (7), pp. 4042-4048. Date of Electronic Publication: 2024 Jun 04 (Print Publication: 2024).

Proposed study designs for approval based on a surrogate endpoint and a post-marketing confirmatory study under FDA's accelerated approval regulations for disease modifying osteoarthritis drugs

Autor: Kraus, V.B. ^†, Simon, L.S. ^‡, Katz, J.N. ^§, Neogi, T. ^‖, Hunter, D. ^¶, Guermazi, A. ^#, Karsdal, M.A. ^††

Publikováno v: In Osteoarthritis and Cartilage April 2019 27(4):571-579